Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gestational Trophoblastic Disease × Leucovorin × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 9 Stomach Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Neoplasms 2 Lung Neoplasms 2 Gastrointestinal Neoplasms 2 Biliary Tract Neoplasms 2 Vipoma 1 Somatostatinoma 1 Resected Liver Metastases From Colorectal Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neutropenia 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1 Insulinoma 1 Glucagonoma 1 Gestational Trophoblastic Disease 1 Gastrinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Islet Cell 1 Adenoma, Islet Cell 1

Interventions

Methotrexate 2 Vacuum Curettage 1 Surgical Procedures, Operative 1 Leucovorin 1 Letrozole 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606539 2017-03-22

SVCGTN

Mansoura University

Phase 2/3 Unknown

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡